11219 Financial Centre Parkway — Little Rock, Arkansas

11219 Financial Centre Parkway is a clinical research site located in Little Rock, Arkansas, United States 72211.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

11219 Financial Centre Parkway has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus and Gastroparesis, Idiopathic Gastroparesis.

Sponsors: Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 11219 Financial Centre Parkway?

11219 Financial Centre Parkway has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 11219 Financial Centre Parkway conducted?

11219 Financial Centre Parkway has 1 clinical trials on record. Their work covers Diabetes Mellitus and Gastroparesis, Idiopathic Gastroparesis.

Is 11219 Financial Centre Parkway accredited by Crixeo Health?

11219 Financial Centre Parkway has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 11219 Financial Centre Parkway?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.